Skip to main content
. 2010 Jul 21;95(10):4743–4747. doi: 10.1210/jc.2010-0864

Figure 1.

Figure 1

A, Study design, showing simultaneous suppression of endogenous testosterone secretion (GnRH = GnRH agonist, leuprolide) and weekly injection of testosterone enanthate for 20 wk. B, Testosterone suppresses hepcidin dose-dependently in men. Log-transformed serum hepcidin levels (ng/ml) are shown at various sampling points in the 20-wk testosterone treatment study.